scispace - formally typeset
P

Philippe Giraud

Researcher at Paris Descartes University

Publications -  192
Citations -  4925

Philippe Giraud is an academic researcher from Paris Descartes University. The author has contributed to research in topics: Radiation therapy & Cancer. The author has an hindex of 32, co-authored 181 publications receiving 4472 citations. Previous affiliations of Philippe Giraud include Curie Institute & Memorial Sloan Kettering Cancer Center.

Papers
More filters
Journal ArticleDOI

Evaluation of microscopic tumor extension in non–small-cell lung cancer for three-dimensional conformal radiotherapy planning

TL;DR: The usual CTV margin of 5 mm appears inadequate to cover the ME for either group, and it must be increased to 8 mm and 6 mm for ADC and SCC, respectively, to cover 95% of the ME.
Journal ArticleDOI

Big Data and machine learning in radiation oncology: State of the art and future prospects.

TL;DR: Methods that could be used to create integrative predictive models in radiation oncology are described and potential uses of machine learning methods such as support vector machine, artificial neural networks, and deep learning are discussed.
Journal ArticleDOI

Respiratory gating for liver tumors: Use in dose escalation

TL;DR: The reproducible decrease in organ motion with gating enabled reduction in gross tumor volume-to-planning target volume margin from 2 to 1 cm, which may allow for dose escalation.
Journal ArticleDOI

Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists

TL;DR: This study compared the delineation of the GTV of intrathoracic tumors by radiologists and radiation oncologists with experience in the field in various centers and found that radiologists tended to delineate smaller volumes and encountered fewer difficulties to delineates 'difficult' cases.
Journal ArticleDOI

Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer

TL;DR: Although most of the recommended techniques have yet to be evaluated in multicenter clinical trials, their use in high-dose radiotherapy to the thorax appears to be rational on the basis of current evidence.